Programmed cell death: Does it play a role in Parkinson's disease?

Annals of Neurology

Volumn 44, Issue 3 SUPPL. 1, 1998, Pages

  Burke, Robert E ^a,b   Kholodilov, Nikolai G ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; AUTOPSY; CELL DEATH; CONFERENCE PAPER; HUMAN; NERVE CELL NECROSIS; NEUROPATHOLOGY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; SUBSTANTIA NIGRA;

EID: 0031668930     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410440719     Document Type: Conference Paper

References (97)

1. Jacobson MD, Weil M, Raff MC. Programmed cell death in animal development. Cell 1997;88:347-354
2. Bredesen DE. Neural apoptosis. Ann Neurol 1995;38:839-851
3. Stefanis L, Burke RE, Greene LA. Apoptosis in neurodegenerative disorders. Curr Opin Neurol 1997;10:299-305
4. Petito CK, Roberts B. Evidence of apoptotic cell death in HIV encephalitis. Am J Pathol 1995;146:1121-1130
5. Nitatori T, Sato N, Waguri S, et al. Delayed neuronal death in the CA 1 pyramidal cell layer of the gerbil hippocampus following transient ischemia is apoptosis. J Neurosci 1995;15: 1001-1011
6. Glucksmann A. Cell deaths in normal vertebrate ontogeny. Biol Rev 1951;26:59-86
7. Hamburger V. History of the discovery of neuronal death in embryos. J Neurobiol 1992;23:1116-1123
8. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972;26:239-257
9. Oppenheim RW. Cell death during development of the nervous system. Annu Rev Neurosci 1991;14:453-501
10. Ellis RE, Yuan J, Horvitz HR. Mechanisms and functions of cell death. Annu Rev Cell Biol 1991;7:663-698
11. Alnemri ES, Livingston DJ, Nicholson DW, et al. Human ICE/CED-3 protease nomenclature. Cell 1996;87:171
12. Martin SJ, Green DR. Protease activation during apoptosis: death by a thousand cuts? Cell 1995;82:349-352
13. Korsmeyer SJ. Regulators of cell death. Trends Genet 1995;11: 101-105
14. Martin DP, Schmidt RE, DiStefano P, Lowry O, Carter J, Johnson E. Inhibitors of protein synthesis and RNA synthesis prevent neuronal death caused by nerve growth factor deprivation. J Cell Biol 1988;106:829-844
15. Oppenheim RW, Prevette D, Tytell M, Homma S. Naturally occurring and induced neuronal death in the chick embryo in vivo requires protein and RNA synthesis: evidence for the role of cell death genes. Dev Biol 1990;138:104-113
16. Kerr JFR, Gobe GC, Winterford CM, Harmon BV. Anatomical methods in cell death. In: Schwartz LM, Osborne BA, eds. Methods in cell biology: cell death. New York: Academic Press, 1995:1-27
17. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119:493-501
18. Grasl-Kraupp B, Ruttkay-Ndicky B, Koudelka H, Bukowska K, Bursch W, Schulte-Hermann R. In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: a cautionary note. Hepatology 1995;21:1465-1468
19. Ferrer I, Tortosa A, Macaya A, et al. Evidence of nuclear DNA fragmentation following hypoxia-ischemia in the infant rat brain, and transient forebrain ischemia in the adult gerbil. Brain Pathol 1994;4:115-122
20. Oo TF, Henchcliffe C, Burke RE. Apoptosis in substantia nigra following developmental hypoxic-ischemic injury. Neuroscience 1995;69:893-901
21. Burke RE, Macaya A, DeVivo D, Kenyon N, Janec EM. Neonatal hypoxic-ischemic or excitotoxic striatal injury results in a decreased adult number of substantia nigra neurons. Neuroscience 1992;50:559-569
22. Macaya A, Burke RE. Effect of striatal lesion with quinolinate on the development of substantia nigra dopaminergic neurons: a quantitative morphological analysis. Dev Neurosci 1992;14: 362-368
23. Prochiantz A, di Porzio U, Kato A, Berger B, Glowinski J. In vitro maturation of mesencephalic dopaminergic neurons from mouse embryos is enhanced in presence of their striatal target cells. Proc Natl Acad Sci USA 1979;76:5387-5391
24. Hemmendinger LM, Garber BB, Hoffmann PC, Heller A. Target neuron-specific process formation by embryonic mesencephalic dopamine neurons in vitro. Proc Natl Acad Sci USA 1981;78:1264-1268
25. Hoffmann PC, Hemmendinger LM, Kotake C, Heller A. Enhanced dopamine cell survival in reaggregates containing target cells. Brain Res 1983;274:275-281
26. Tomozawa Y, Appel SH. Soluble striatal extracts enhance development of mesencephalic dopaminergic neurons in vitro. Brain Res 1986;399:111-124
27. Barde YA. Trophic factots and neuronal survival. Neuron 1989; 2:1525-1534
28. Clarke PGH. Neuronal death in the development of the vertebrate nervous system. Trends Neurosci 1985;8:345-349
29. Janec E, Burke RE. Naturally occurring cell death during postnatal development of the substantia nigra of rhe rat. Mol Cell Neurosci 1993;4:30-35
30. Oo TF, Burke RE. The time course of developmental cell death in phenotypically defined dopaminergic neurons of the substantia nigra. Dev Brain Res 1997;98:191-196
31. Tepper JM, Damlama M, Trent F. Postnatal changes in the distribution and morphology of rat substantia nigra dopaminergic neurons. Neuroscience 1994;60:469-477
32. Macaya A, Munell F, Gubits RM, Butke RE. Apoptosis in substantia nigra following developmental striatal excitotoxic injury. Proc Natl Acad Sci USA 1994;91:8117-8121
33. Kelly WJ, Burke RE. Apoptotic neuron death in rat substantia nigra induced by striatal excitotoxic injury is developmentally dependent. Neurosci Lett 1996;220:85-88
34. Marti MJ, James CJ, Oo TF, Kelly WJ, Burke RE. Early developmental destruction of terminals in the striatal target induces apoptosis in dopamine neurons of the substantia nigra. J Neurosci 1997;17:2030-2039
35. Pilar G, Landmesser L. Ultrastructural differences during embryonic cell death in notmal and peripherally deprived ciliary ganglia. J Cell Biol 1976;68:339-356
36. Cunningham TJ. Naturally occurring neuron death and its regulation by developing neural pathways. Int Rev Cytol 1982;74: 163-186
37. Walkinshaw G, Waters CM. Neurotoxin induced cell death in neuronal PC12 cells is mediated by induction of apoptosis. Neuroscience 1994;63:975-987
38. Jeon BS, Jackson-Lewis V, Burke RE. 6-Hydroxydopamine lesion of the rat substantia nigra: time course and morphology of cell death. Neurodegeneration 1995;4:131-137
39. Dipasquale B, Marini AM, Youle RJ. Apoptosis and DNA degradation induced by 1-methyl-4-phenylpyridinium in neurons. Biochem Biophys Res Comm 1991;181:1442-1448
40. +) in ventral mesencephalic striatal co-culture in rat. Neurosci Lett 1994; 170:191-194
41. Mutoh T, Tokuda A, Marini AM, Fujiki N. 1-methyl-4-phenylpyridinium kills differentiated PC12 cells with a concomitant change in protein phosphorylation. Brain Res 1994; 661:51-55
42. Hartley A, Stone JM, Heron C, Cooper JM, Schapira AHV. Complex I inhibitors induce dose dependent apoptosis in PC12 cells televance to Parkinson's disease. I Neurochem 1994;63: 1987-1990
43. (+)) causes DNA fragmentation and increases the Bcl-2 expression in human neuroblastoma, SH-SY5Y cells, through different mechanisms. Brain Res 1995;704:240-245
44. Jackson-Lewis V, Jakowec M, Burke RE, Przedborski S. Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine. Neurodegeneration 1995;4:257-269
45. Tatton NA, Kish SJ. In situ detection of apoptotic nuclei in the substantia nigta compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange. Neuroscience 1997;77:1037-1048
46. Hassouna I, Wickert H, Zimmermann M, Gillardon F. Increase in Bax expression in substantia-nigra following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment of mice. Neurosci Lett 1996;204:85-88
47. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993;74:609-619
48. Korsmeyer SJ, Shutter JR, Veis DJ, Merry DE, Oltvai ZN. Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death. Semin Cancer Biol 1993;4:327-332
49. Trimmer PA, Smith TS, Jung AB, Bennett JP Jr. Dopamine neurons from transgenic mice with a knockout of the p53 gene resist MPTP neurotoxicity. Neurodegeneration 1996;5:233-239
50. Lane DP, Lu X, Hupp T, Hall PA. The role of p53 protein in the apoptotic response. Phil Trans R Soc Lond 1994;345:277-280
51. Yonish-Rouach E, Grunwald D, Wilder S, et al. p53-Mediated cell death: relationship to cell cycle control. Mol Cell Biol 1993;13:1415-1423
52. Chopp M, Li Y, Zhang ZG, Freytag SO. p53 Expression in brain aftet middle cerebral artery occlusion in the rat. Biochem Biophys Res Comm 1992;182:1201-1207
53. Smeyne RJ, Goldowitz D. Development and death of external granular layer cells in the weaver mouse cerebellum: a quantitative study. J Neurosci 1989;9:1608-1620
54. Migheli A, Attanasio A, Lee W-H, Bayer SA, Ghetti B. Detection of apoptosis in weaver cerebellum by electron microscopic in situ end-labeling of fragmented DNA. Neurosci Lett 1995; 199:53-56
55. Wullner U, Loschmann PA, Wellet M, Klockgether T. Apoptotic cell death m the cerebellum of mutant weaver and lurcher mice. Neurosci Lett 1995;200:109-112
56. Harrison SMW, Roffler-Tarlov S. Apoptotic and non-apoptotic cell death in the mouse mutant weaver [abstract]. Soc Neurosci Abstr 1995;424:16
57. Oo TF, Blazeski R, Harrison SMW, et al. Neuron death in the substantia nigra of weaver mouse occurs late in development and is not apoptotic. J Neurosci 1996;16:6134-6145
58. Clarke PGH. Developmental cell death: morphological diversity and multiple mechanisms. Anat Embryol 1990;181:195-213
59. Patil N, Cox DR, Bhat D, Faham M, Myers RM, Peterson AS. A potassium channel mutation in weaver mice implicates membrane excitability in granule cell differentiation. Nature Genet 1995;11:126-129
60. Anglade P, Vyas S, Javoy-Agid F, et al. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Histol Histopathol 1997;12:25-31
61. Mochizuki H, Goto K, Mori H, Mizuno Y. Histochemical detection of apoptosis in Parkinson's disease. J Neurol Sci 1996; 137:120-123
62. Tompkins MM, Basgall EJ, Zamrini E, Hill WD. Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons. Am J Pathol 1997;150:119-131
63. Kosel S, Egensperger R, von Eitzen U, Mehraein P, Graeber MB. On the question of apoptosis in the parkinsonian substantia nigra. Acta Neuropathol (Berl) 1997;93:105-108
64. Lowe J, Mayer RJ, Landon M. Ubiquitin in neurodegenerative diseases. Brain Pathol 1993;3:55-65
65. Gai WP, Blessing WW, Blumbergs PC. Ubiquitin-positive degenerating neurites in the brainstem in Parkinson's disease. Brain 1995;118:1447-1459
66. Schwartz LM, Myer A, Kosz L, Engelstein M, Maier C. Activation of polyubiquitin gene expression during developmentally programmed cell death. Neuron 1990;5:411-419
67. Duffy PE, Tennyson VM. Phase and electron microscopic observations of Lewy bodies and melanin granules in the substantia nigra and locus ceruleus in Parkinson's disease. J Neuropathol Exp Neurol 1965;24:398-414
68. Goldman JE, Yen S-H, Chiu F-C, Peress NS. Lewy bodies of Parkinson's disease contain neurofilament antigens. Science 1983;221:1082-1084
69. Forno LS, Sternberger LA, Sternberger NH, Strefling AM, Swanson K, Eng LF. Reaction of Lewy bodies with antibodies to phosphorylated and nonphosphorylated neurofilaments. Neurosci Lett 1986;64:253-258
70. Bancher C, Lassman H, Budka H, et al. An antigenic profile of Lewy bodies: immunocytochemical indication for protein phosphorylation and ubiquitination. J Neuropathol Exp Neurol 1989;48:81-93
71. Lew J, Wang JH. Neuronal cdc2-like kinase. Trends Biol Sci 1995;20:33-37
72. Brion J-P, Couck A-M. Cortical and brainstem-type Lewy bodies are immunoreactive for the cyclin-dependent kinase 5. Am J Pathol 1995;147:1465-1476
73. Nakamura S, Kawamoto Y, Nakano S, Ikemoto A, Akiguchi I, Kimura J. Cyclin-dependent kinase 5 in Lewy body-like inclusions in anterior horn cells of a patient with sporadic amyotrophic lateral sclerosis. Neurology 1997;48:267-270
74. Henchcliffe C, Burke RE. Increased expression of cyclin-dependent kinase 5 in induced apoptotic neuron death in rat substantia nigra. Neurosci Lett 1997;230:41-44
75. Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 1997;276:2045-2047
76. Golbe LI, Di Iorio G, Bonavita V, Miller DC, Duvoisin RC. Autosomal dominant Parkinson's disease. Ann Neurol 1990;27: 276-282
77. Ueda K, Fukushima H, Masliah E, et al. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc Natl Acad Sci USA 1993;90:11282-11286
78. Jakes R, Spillantini MG, Goedert M. Identification of two distinct synucleins from human brain. FEBS Lett 1994;345:27-32
79. Maroteaux L, Scheller RH. The rat brain synucleins: family of proteins transiently associated with neuronal membrane. Mol Brain Res 1991;11:335-343
80. Maroteaux L, Campanelli JT, Scheller RH. Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J Neurosci 1988;8:2804-2815
81. Iwai A, Masliah E, Yoshimoto M, et al. The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system. Neuron 1995; 14:467-475
82. Irizarry MC, Kim TW, McNamara M, et al. Characterization of the precursor protein of the non-A beta component of senile plaques (NACP) in the human central nervous system. J Neuropathol Exp Neurol 1996;55:889-895
83. George JM, Jin H, Woods WS, Clayton DF. Characterization of a novel protein regulated during the critical period for song learning in the zebra finch. Neuron 1995;15:361-372
84. Spillantini MG, Schmidt ML, Lee VMY, Trojanowski JQ, Jakes R, Goedert M. α-Synuclein in Lewy bodies. Nature 1997; 388:839-840
85. Liang P, Pardee AB. Differential display of eukaryotic RNA by means of the polymerase chain reaction. Science 1992;257:967-971
86. Livesey FJ, Hunt SP. Identifying changes in gene expression in the nervous system: mRNA differential display. Trends Neurosci 1996;19:84-88
87. Kholodilov NG, Neystat M, Burke RE. Investigation of apoptotic neuron death in substantia nigra with mRNA differential display [abstract]. Neurology 1997;48:A322
88. Kholodilov NG, Neystat M, Burke RE. mRNAs overexpressed during induced apoptosis in substantia nigra identified by RNA differential display [abstract]. Soc Neurosci Abstr 1997;23:631
89. Lindvall O, Rehncrona S, Brundin P, et al. Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. Arch Neurol 1989;46:615-631
90. Lindvall O, Brundin P, Widner H, et al. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 1990;247:574-577
91. Lindvall O, Sawle G, Widner H, et al. Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease. Ann Neurol 1994;35:172-180
92. Yurek DM, Sladek JR. Dopamine cell replacement: Parkinson's disease. Annu Rev Neurosci 1990;13:415-440
93. Mahalik TJ, Hahn WE, Clayton GH, Owens GP. Programmed cell death in developing grafts of fetal substantia nigra. Exp Neurol 1994;129:27-36
94. Zawada WM, Zastrow DJ, Clarkson ED, Adams FS, Bell KP, Freed CR. Growth factors improve immediate survival of embrymic dopamine neurons after transplantation into rats. Brain Res 1998;786:96-103
95. Fahn S. Controversies in the therapy of Parkinson's disease. Adv Neurol 1996;69:477-486
96. Ziv I, Melamed E, Nardi N, et al. Dopamine induces apoptosis like cell death in cultured chick sympathetic neurons: a possible novel pathogenetic mechanism in Parkinsons disease. Neurosci Lett 1994;170:136-140
97. Walkinshaw G, Waters CM. Induction of apoptosis in catecholaminergic PC12 cells by L-dopa. J Clin Invest 1995;95: 2458-2464